NCT02794181
Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD) No drug interventions Not Available Not Available completed NCT03483961
Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults No drug interventions prevention 2 completed NCT04909411
Consequences of a Maternal-fetal Chikungunya Virus Infection No drug interventions diagnostic Not Available completed NCT04455919
Yoga for Chronic Chikungunya No drug interventions supportive_care Not Available terminated NCT03631719
Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia No drug interventions Not Available Not Available completed NCT03028441
Phase I Trial of Measles Vectored Chikungungya Vaccine No drug interventions prevention 1 completed NCT01489358
Chikungunya Virus Vaccine Trial in Healthy Adults No drug interventions prevention 1 completed NCT02861586
Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine prevention 2 completed NCT02562482
Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults No drug interventions prevention 2 completed NCT04838444
Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) prevention 3 active_not_recruiting NCT04786444
Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults prevention 3 completed NCT02553369
Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection No drug interventions Not Available Not Available completed NCT04441905
Phase 1 Study of SAR440894 vs Placebo No drug interventions treatment 1 completed NCT06007183
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination No drug interventions prevention 3 recruiting NCT06028841
A Clinical Phase 3 Study of VLA1553 in Adult Participants With Human Immunodeficiency Virus (HIV) prevention 3 recruiting NCT04546724
Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults prevention 3 completed NCT02230163
Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins treatment 1 / 2 unknown_status NCT03635086
Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005) prevention 2 completed NCT06106581
A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years prevention 2 active_not_recruiting NCT03807843
Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006) No drug interventions prevention 2 completed